BriaCell Therapeutics Corp. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-01-31
|
-0.37
|
0.00
|
0.37
|
100.00%
|
|
2022-10-31
|
-0.33
|
-0.07
|
0.26
|
78.79%
|
|
2022-07-31
|
-0.35
|
-1.02
|
-0.67
|
-191.43%
|
|
2022-04-30
|
-0.17
|
-0.32
|
-0.15
|
-88.24%
|
|
2022-01-31
|
-0.15
|
-0.24
|
-0.09
|
-60.00%
|
|
2021-10-31
|
0.00
|
-0.16
|
0.00
|
0.00%
|
|
2021-04-30
|
0.00
|
0.61
|
0.00
|
0.00%
|
|
2021-01-31
|
0.00
|
-0.29
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-10-31
|
-0.07
|
|
2022-07-31
|
-1.90
|
|
2020-07-31
|
-5.21
|
|
2019-07-31
|
-7.51
|
|
2018-07-31
|
-9.65
|
|
2017-07-31
|
-7.16
|
|
2016-07-31
|
-5.82
|
|
2015-07-31
|
-15.75
|
|
2014-07-31
|
-139.12
|
|
2013-07-31
|
-6.39
|
|
2012-07-31
|
-14.75
|